- Home
- FOXF vs NVCR Comparison
FOXF vs NVCR Comparison
Compare FOXF & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- NVCR
- Stock Information
- Founded
- FOXF 2007
- NVCR 2000
- Country
- FOXF United States
- NVCR Jersey
- Employees
- FOXF N/A
- NVCR N/A
- Industry
- FOXF Motor Vehicles
- NVCR Medical/Dental Instruments
- Sector
- FOXF Consumer Discretionary
- NVCR Health Care
- Exchange
- FOXF Nasdaq
- NVCR Nasdaq
- Market Cap
- FOXF 1.6B
- NVCR 1.8B
- IPO Year
- FOXF N/A
- NVCR 2015
- Fundamental
- Price
- FOXF $37.00
- NVCR $17.49
- Analyst Decision
- FOXF Hold
- NVCR Buy
- Analyst Count
- FOXF 6
- NVCR 5
- Target Price
- FOXF $46.17
- NVCR $26.60
- AVG Volume (30 Days)
- FOXF 293.5K
- NVCR 1.3M
- Earning Date
- FOXF 10-31-2024
- NVCR 10-30-2024
- Dividend Yield
- FOXF N/A
- NVCR N/A
- EPS Growth
- FOXF N/A
- NVCR N/A
- EPS
- FOXF 0.98
- NVCR N/A
- Revenue
- FOXF $1,345,575,000.00
- NVCR $549,964,000.00
- Revenue This Year
- FOXF N/A
- NVCR $16.23
- Revenue Next Year
- FOXF $10.04
- NVCR $6.09
- P/E Ratio
- FOXF $37.96
- NVCR N/A
- Revenue Growth
- FOXF N/A
- NVCR 8.33
- 52 Week Low
- FOXF $34.56
- NVCR $10.87
- 52 Week High
- FOXF $86.14
- NVCR $24.74
- Technical
- Relative Strength Index (RSI)
- FOXF 40.65
- NVCR 43.24
- Support Level
- FOXF $36.65
- NVCR $15.61
- Resistance Level
- FOXF $38.36
- NVCR $17.31
- Average True Range (ATR)
- FOXF 1.35
- NVCR 1.29
- MACD
- FOXF -0.21
- NVCR 0.05
- Stochastic Oscillator
- FOXF 20.19
- NVCR 11.59
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.